These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15693407)

  • 1. Three surveillance strategies for vancomycin-resistant enterococci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model.
    Lee TA; Hacek DM; Stroupe KT; Collins SM; Peterson LR
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):39-46. PubMed ID: 15693407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based surveillance for vancomycin-resistant enterococci: utility of screening stool specimens submitted for Clostridium difficile toxin assay.
    Leber AL; Hindler JF; Kato EO; Bruckner DA; Pegues DA
    Infect Control Hosp Epidemiol; 2001 Mar; 22(3):160-4. PubMed ID: 11310695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications.
    Shadel BN; Puzniak LA; Gillespie KN; Lawrence SJ; Kollef M; Mundy LM
    Infect Control Hosp Epidemiol; 2006 Oct; 27(10):1068-75. PubMed ID: 17006814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program.
    Hacek DM; Bednarz P; Noskin GA; Zembower T; Peterson LR
    J Clin Microbiol; 2001 Mar; 39(3):1152-4. PubMed ID: 11230446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of vancomycin-resistant enterococci (VRE) in stool specimens submitted for Clostridium difficile toxin testing.
    Özsoy S; İlki A
    Braz J Microbiol; 2017; 48(3):489-492. PubMed ID: 28389190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for positive admission surveillance cultures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in a neurocritical care unit.
    Minhas P; Perl TM; Carroll KC; Shepard JW; Shangraw KA; Fellerman D; Ziai WC
    Crit Care Med; 2011 Oct; 39(10):2322-9. PubMed ID: 21705905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A hidden reservoir of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in patients newly admitted to an acute rehabilitation hospital.
    Rabinowitz RP; Kufera JA; Makley MJ
    PM R; 2012 Jan; 4(1):18-22. PubMed ID: 22269450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
    Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
    J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prediction rule for identifying patients with vancomycin-resistant enterococci (VRE) at the time of admission to the intensive care unit in a low VRE prevalence setting.
    Yoon YK; Kim HJ; Lee WJ; Lee SE; Yang KS; Park DW; Sohn JW; Kim MJ
    J Antimicrob Chemother; 2012 Dec; 67(12):2963-9. PubMed ID: 22888271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country.
    Ulu-Kilic A; Özhan E; Altun D; Perçin D; Güneş T; Alp E
    Am J Infect Control; 2016 Apr; 44(4):e45-9. PubMed ID: 26775930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications for vancomycin-resistant Enterococcus colonization associated with Clostridium difficile infections.
    Fujitani S; George WL; Morgan MA; Nichols S; Murthy AR
    Am J Infect Control; 2011 Apr; 39(3):188-93. PubMed ID: 21458682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force.
    Weber SG; Huang SS; Oriola S; Huskins WC; Noskin GA; Harriman K; Olmsted RN; Bonten M; Lundstrom T; Climo MW; Roghmann MC; Murphy CL; Karchmer TB
    Am J Infect Control; 2007 Mar; 35(2):73-85. PubMed ID: 17327185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving efficiency in active surveillance for methicillin-resistant Staphylococcus aureus or vancomycin-resistant Enterococcus at hospital admission.
    Morgan DJ; Day HR; Furuno JP; Young A; Johnson JK; Bradham DD; Perencevich EN
    Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1230-5. PubMed ID: 21028966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted surveillance to identify children colonized with vancomycin-resistant Enterococcus in the pediatric intensive care unit.
    Milstone AM; Maragakis LL; Carroll KC; Perl TM
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):95-8. PubMed ID: 19929692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the assessment of vancomycin-resistant enterococci by routine screening.
    Huang SS; Rifas-Shiman SL; Pottinger JM; Herwaldt LA; Zembower TR; Noskin GA; Cosgrove SE; Perl TM; Curtis AB; Tokars JL; Diekema DJ; Jernigan JA; Hinrichsen VL; Yokoe DS; Platt R;
    J Infect Dis; 2007 Feb; 195(3):339-46. PubMed ID: 17205471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting.
    Katz KC; Gardam MA; Burt J; Conly JM
    Infect Control Hosp Epidemiol; 2001 Apr; 22(4):219-21. PubMed ID: 11379713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule.
    Tacconelli E; Karchmer AW; Yokoe D; D'Agata EM
    Clin Infect Dis; 2004 Oct; 39(7):964-70. PubMed ID: 15472847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients.
    Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):130-8. PubMed ID: 19128183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.